Market Place
Sourcing Support
Prime Medicine to Participate in Upcoming Investor Conferences
06 Nov 2024 //
GLOBENEWSWIRE
Prime Medicine Presents Wilson’s Disease Data At ESGCT Congress
24 Oct 2024 //
GLOBENEWSWIRE
Prime Medicine Highlights Preclinical Data In Wilson’s Disease
15 Oct 2024 //
GLOBENEWSWIRE
BMS pays Prime $110M to form T-cell therapy pact
01 Oct 2024 //
PRESS RELEASE
Prime Medicine Collab with BMS To Develop Edited T-Cell Therapies
30 Sep 2024 //
GLOBENEWSWIRE
Prime Medicine Unveils Strategically Focused Pipeline
30 Sep 2024 //
GLOBENEWSWIRE
Prime Medicine to Participate in Upcoming Investor Conferences
28 Aug 2024 //
GLOBENEWSWIRE
Prime Medicine Reports Q2 2024 Results And Provides Business Updates
08 Aug 2024 //
GLOBENEWSWIRE
Prime Medicine to Present at Upcoming Investor Conferences
30 May 2024 //
GLOBENEWSWIRE
Prime Medicine To Present At H.C. Wainwright BioConnect Conference
13 May 2024 //
GLOBENEWSWIRE
Prime Medicine Q1 2024 Financials, Business Update
10 May 2024 //
GLOBENEWSWIRE
Prime Medicine CGD Gene Editing Data For PM359
08 May 2024 //
GLOBENEWSWIRE
Prime Medicine To Participate At Milken Global Conference
01 May 2024 //
GLOBENEWSWIRE
Prime editing comes of age as FDA clears human trials
30 Apr 2024 //
PHARMAPHORUM
Prime Medicine Gets FDA IND OK for PM359 in CGD
29 Apr 2024 //
GLOBENEWSWIRE
Prime Medicine Showcasing Prime Editing Potential At Scientific Meetings
23 Apr 2024 //
GLOBENEWSWIRE
Prime Medicine Reports Full Year 2023 Financial Results
01 Mar 2024 //
GLOBENEWSWIRE
Prime Medicine to Participate in Upcoming Investor Conferences
28 Feb 2024 //
GLOBENEWSWIRE
Prime Medicine Announces Closing of Upsized Public Offering
20 Feb 2024 //
GLOBENEWSWIRE
Prime Medicine Announces Proposed Public Offering of Common Stock
14 Feb 2024 //
GLOBENEWSWIRE
Prime Medicine to Present at 6th Annual Biotechnology Conference
01 Feb 2024 //
GLOBENEWSWIRE
Prime Medicine Receives Up to $15 Million from Cystic Fibrosis Foundation
25 Jan 2024 //
GLOBENEWSWIRE
Prime Medicine and Myeloid Announce Settlement of Pending Disputes
05 Jan 2024 //
PR NEWSWIRE
Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer
05 Jan 2024 //
GLOBENEWSWIRE
Prime Medicine to Present at 42nd Annual J.P. Morgan Healthcare Conference
02 Jan 2024 //
GLOBENEWSWIRE
Prime Medicine to Present at Upcoming Investor Conferences
08 Nov 2023 //
GLOBENEWSWIRE
Prime Medicine Reports Third Quarter 2023 Financial Results
03 Nov 2023 //
GLOBENEWSWIRE
Prime Medicine showcases its first in vivo editing data in monkeys and mice
27 Oct 2023 //
ENDPTS
Prime Medicine Presents First-ever Prime Editing Data in Non-human Primates
27 Oct 2023 //
GLOBENEWSWIRE
Prime Medicine Presents First In Vivo Proof-of-Concept Prime Editing Data
24 Oct 2023 //
GLOBENEWSWIRE
Prime Medicine to Highlight Developments Across Prime Editing Pipeline
17 Oct 2023 //
GLOBENEWSWIRE
Prime Medicine to Present at Upcoming Investor Conferences
19 Sep 2023 //
GLOBENEWSWIRE
Prime Medicine to Present at Upcoming Investor Conferences
31 Aug 2023 //
GLOBENEWSWIRE
Prime Medicine Reports Second Quarter 2023 Financial Results
07 Aug 2023 //
GLOBENEWSWIRE
Prime Medicine and Cimeio Therapeutics Announce Research Collaboration
22 Jun 2023 //
GLOBENEWSWIRE
Prime Medicine partners with Versant-backed biotech
22 Jun 2023 //
ENDPTS
Prime Medicine considers focus on autoimmune diseases for CAR-T, CEO says
15 Jun 2023 //
ENDPTS
Prime Medicine to Present at Investor Conferences in June
31 May 2023 //
GLOBENEWSWIRE
Prime Medicine to Present at Virtual Investor Conferences in May
17 May 2023 //
GLOBENEWSWIRE
Prime Medicine to Present Preclinical Data Highlighting Prime Editing Technology
17 May 2023 //
GLOBENEWSWIRE
Prime Medicine Reports First Quarter 2023 Financial Results
11 May 2023 //
GLOBENEWSWIRE
Prime Medicine Reports Fourth Quarter and Full Year 2022 Financial Results
09 Mar 2023 //
GLOBENEWSWIRE
Prime Medicine to Present at Cowen 43rd Annual Health Care Conference
27 Feb 2023 //
GLOBENEWSWIRE
Prime Medicine Announces Recent Progress & Highlights 2023 Strategic Priorities
09 Jan 2023 //
GLOBENEWSWIRE
Prime Medicine to Present at 41st Annual J.P. Morgan Healthcare Conference
03 Jan 2023 //
GLOBENEWSWIRE
Prime initiated at buy at Jefferies on next-generation gene editing platform
14 Nov 2022 //
SEEKING ALPHA
Prime Medicine: CRISPR 3.0 Company
24 Oct 2022 //
SEEKINGALPHA
Prime Medicine Announces Closing of Upsized Initial Public Offering
24 Oct 2022 //
GLOBENEWSWIRE
Biotech firm Prime Medicine valued at $1.8 bln in strong debut
21 Oct 2022 //
REUTERS
Prime Medicine Announces Pricing of Upsized Initial Public Offering
19 Oct 2022 //
BUSINESSWIRE
Prime Medicine Appoints Three New Directors to its Board of Directors
11 Aug 2022 //
BUSINESSWIRE
Prime Medicine Announces Addition of Capabilities to Prime Editing Platform
19 Oct 2021 //
BIOSPACE
